Healthcare Services

Digital Biomarkers Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Digital Biomarkers Market In 2026 And What Value Is Projected For 2030?

The digital biomarkers market has experienced significant growth in recent years. It is anticipated to increase from $4.96 billion in 2025 to $6.26 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.3%. This historical expansion can be attributed to several factors, including the rising adoption of consumer wearables, the proliferation of mobile health applications, an increase in the prevalence of chronic diseases, the availability of advanced biosensors, and a growing interest in preventive healthcare.

The digital biomarkers market is projected to experience substantial expansion in the coming years, set to reach $15.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 26.0%. Key drivers for this projected growth include escalating investments in digital health platforms, a surging need for personalized healthcare monitoring, the broadening scope of predictive health analytics, deeper integration with electronic health records, and enhanced regulatory backing for digital biomarkers. Significant trends anticipated during this period encompass the wider adoption of wearable health monitoring devices, increased deployment of continuous remote patient monitoring, expanding incorporation of AI-based health analytics, the growth of sensor-based disease tracking, and a heightened emphasis on gathering real-time health data.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp

What Major Drivers Are Influencing Demand In The Digital Biomarkers Market?

The increasing occurrence of chronic illnesses is anticipated to boost the expansion of the digital biomarkers market. These are long-term health conditions that typically advance slowly and persist for an extended duration, often for life. The likelihood of developing chronic diseases rises with age-related conditions such as osteoarthritis, Alzheimer’s disease, and heart disease, compounded by high consumption of processed foods and reduced physical activity. Digital biomarkers are utilized in managing chronic diseases to continuously track health metrics and disease progression in real time, thereby enabling more personalized and timely interventions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of US adults, representing approximately 194 million people, reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the growing prevalence of chronic diseases will stimulate the growth of the digital biomarker market.

What Are The Key Segments Of The Digital Biomarkers Market?

The digital biomarkers market covered in this report is segmented –

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types

2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices

3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications

4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:

1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors

2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps

3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors

4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

Which Upcoming Trends Are Expected To Influence The Digital Biomarkers Market?

Leading entities within the digital biomarker market are increasingly employing strategic alliances to broaden their market presence and improve their range of services. Such a partnership commonly signifies a collaborative bond among multiple organizations, uniting their assets, specialized knowledge, and endeavors toward shared objectives. An illustrative example occurred in September 2023, when ProofPilot, a clinical trial automation provider based in the US, established a strategic collaboration with Eli Lilly and Company, a US-based pharmaceutical firm. The goal was to incorporate Lilly’s innovative, patent-pending sensor cloud platform, Magnol.AI, into ProofPilot’s existing technology. Magnol.AI stands as an advanced platform, engineered for the secure and straightforward handling of high-frequency sensor data. The objective of this alliance is to elevate the quality of digital health research execution and expedite pre-competitive biomedical studies. Through this integration, researchers are empowered to leverage real-time data science functions and extract profound understanding from sensor data, thereby connecting with clinician and patient-reported outcomes to propel advancements in digital health and biomarker research.

Who Are The Leading Companies Operating In The Digital Biomarkers Market?

Major companies operating in the digital biomarkers market are Pfizer Inc, Bayer AG, F Hoffmann-La Roche Ltd, Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc, Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Ōura Health Oy., Evidation Health Inc, AliveCor Inc, Empatica Inc, ActiGraph LLC, VivoSense Inc, BioSensics LLC, Koneksa Health Inc, ATCOR Medical Pty Ltd, Brainomix Limited

Read the full digital biomarkers market report here:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Digital Biomarkers Market?

North America was the largest region in the digital biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Digital Biomarkers Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19397&type=smp

Browse Through More Reports Similar to the Global Digital Biomarkers Market 2026, By The Business Research Company

Digital Publishing Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-publishing-global-market-report

Digital Pc Games Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-pc-games-global-market-report

Digital Payments Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-payments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795